HALEY GRAVELY: Open Payments
NPI 1043942766 · POULSBO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,211 in 56 payments from 14 companies in 2025. Trend: 2023 $1,987 · 2024 $1,340 · 2025 $1,211
Food & beverage: $1,112Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $379 |
| Novartis Pharmaceuticals Corporation | 14 | $221 |
| ABBVIE INC. | 8 | $163 |
| Organon LLC | 3 | $162 |
| UCB, Inc. | 3 | $67 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
Products named: TREMFYA, COSENTYX, SKYRIZI, Bimzelx, Zoryve, RINVOQ, LIBTAYO, TALTZ.
Industry payments across WA — which companies pay providers there.
